These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3403250)

  • 1. Apolipoproteins.
    Fukunaga FH
    Hawaii Med J; 1988 Jun; 47(6):291. PubMed ID: 3403250
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoproteins and risk of coronary heart disease.
    Connelly PW
    CMAJ; 1991 May; 144(10):1277. PubMed ID: 2025824
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apolipoproteins and coronary heart disease].
    Beigl Y; Green P; Lurie Y
    Harefuah; 1987 Apr; 112(8):405-7. PubMed ID: 3315898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are apolipoproteins better indicators of ischemic heart disease than serum lipids?].
    Klosiewicz-Latoszek L
    Kardiol Pol; 1989; 32(1):41-9. PubMed ID: 2681921
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum apolipoprotein measurements: an improved discriminator for assessing coronary heart disease risk.
    Naito HK
    Compr Ther; 1987 Nov; 13(11):43-52. PubMed ID: 3315418
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoproteins, the lipid hypothesis and ischaemic heart disease.
    Avogaro P
    Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of different lipid measures to predict coronary heart disease.
    Sierra-Johnson J; Romero-Corral A; Lopez-Jimenez F
    JAMA; 2008 Jan; 299(1):35; author reply 36. PubMed ID: 18167403
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of different lipid measures to predict coronary heart disease.
    Remick J; Underberg JA; Shah NR
    JAMA; 2008 Jan; 299(1):35-6; author reply 36. PubMed ID: 18167402
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoproteins and long-term prognosis in coronary heart disease patients.
    Benderly M; Boyko V; Goldbourt U
    Am Heart J; 2009 Jan; 157(1):103-10. PubMed ID: 19081405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAD: maybe cholesterol isn't the culprit.
    Zoler ML
    Geriatrics; 1984 Sep; 39(9):113, 117, 120. PubMed ID: 6468933
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
    Shima K; Tanaka A; Ejiri N; Maezawa H
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid and apolipoprotein levels in health and disease].
    Steinerová A; Stozický F; Dudek J; Novák J; Polívková V; Topolcan O; Karlícek V
    Vnitr Lek; 1987 Feb; 33(2):105-12. PubMed ID: 3824933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids].
    Mordasini R; Riesen W
    Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental evaluation of an enzymatic determination of lipids in the lipoprotein fractions obtained by electrophoresis and clinical investigation of alpha-lipoprotein lipids and serum apolipoprotein A in ischemic heart disease].
    Ikeda H; Maeda J
    Rinsho Byori; 1982 Oct; 30(10):1127-31. PubMed ID: 7182585
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apolipoproteins and screening for coronary atherosclerosis].
    Cano Y; Malandain H
    Presse Med; 1983 Apr; 12(19):1236. PubMed ID: 6221307
    [No Abstract]   [Full Text] [Related]  

  • 20. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.